Form 4: Cyanotech Director Michael Davis Increases Stake in Company

Director Michael Davis has increased his stake in Cyanotech through recent stock purchases made under a 10b5-1 trading plan.

Summary

• Michael Davis, a director and 10% owner of Cyanotech Corporation, has reported changes in his beneficial ownership of the company's stock.
• On August 21, 2024, Davis purchased 5,000 shares of Cyanotech common stock at a price of $0.75 per share.
• On August 22, 2024, he purchased an additional 5,000 shares at $0.76 per share.
• These transactions were made pursuant to a pre-arranged 10b5-1 trading plan adopted on March 6, 2024.
• Following these purchases, Davis directly owns 12,119 shares and indirectly owns 1,226,736 shares through various trusts, including the Michael Arlen Davis Revocable Trust, Nyracai Davis Irr. Trust, Nettizanne J. Davis Irr. Trust, Nettizanne Johnstone Davis GST Exempt Trust, and Nyracai Johnstone Davis GST Exempt Trust.
• He also indirectly owns 31,250 shares through his spouse.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed favorably, but the purchases are relatively small and executed under a pre-existing plan, reducing the impact.

Positives

• A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored by investors as an indicator of management's confidence in the company's prospects. It's a common practice, especially when executed under a pre-arranged 10b5-1 trading plan to avoid accusations of trading on inside information.

Key Dates

Keywords

Cyanotech, insider trading, Form 4, beneficial ownership, Michael Davis, stock purchase, 10b5-1 plan